홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

(5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 2-ethoxymethyl-4-(1-hydroxy-1-methylethyl)-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate → HCID 178467658, 화합물

HRID 265134
노트
인쇄 미리보기

반응식

HRID 265134 반응식
[CH2:1]([O:3][CH2:4][C:5]1[N:6]([CH2:25][C:26]2[CH:31]=[CH:30][C:29]([C:32]3[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=3[C:38]3[N:42](C(C4C=CC=CC=4)(C4C=CC=CC=4)C4C=CC=CC=4)[N:41]=[N:40][N:39]=3)=[CH:28][CH:27]=2)[C:7]([C:14]([O:16][CH2:17][C:18]2[O:19][C:20](=[O:24])[O:21][C:22]=2[CH3:23])=[O:15])=[C:8]([C:10]([OH:13])([CH3:12])[CH3:11])[N:9]=1)[CH3:2]>C(O)(=O)C>[CH2:1]([O:3][CH2:4][C:5]1[N:6]([CH2:25][C:26]2[CH:31]=[CH:30][C:29]([C:32]3[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=3[C:38]3[NH:42][N:41]=[N:40][N:39]=3)=[CH:28][CH:27]=2)[C:7]([C:14]([O:16][CH2:17][C:18]2[O:19][C:20](=[O:24])[O:21][C:22]=2[CH3:23])=[O:15])=[C:8]([C:10]([OH:13])([CH3:11])[CH3:12])[N:9]=1)[CH3:2]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 1

HCID 19036259(5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 2-ethoxymethyl-4-(1-hydroxy-1-methylethyl)-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate

생성물 1

HCID 178467658HCID 178467658, 화합물수율 89.2%

시약·촉매·용매 1

HCID 176Acetic Acid용매

실험 절차

Following a procedure similar to that described in Example 82 (b), but detritylating 456 mg of (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 2-ethoxymethyl-4-(1-hydroxy-1-methylethyl)-1-{4-[2-(trityltetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate [prepared as described in step (a) above] with a 25% v/v aqueous solution of acetic acid, 286 mg of the title compound were obtained as crystals, melting at 166°-167.5° C.

출처 및 근거

ORD 기록
ord-b5402b340fac496a96d34d86054c1913
출처 데이터셋
uspto-grants-1997_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05646171

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트